Add Yahoo as a preferred source to see more of our stories on Google. Dr Sue Pavord:’It was scary. I was a mother of three kids in their 20s, and these were the people we were seeing dying’ - ...

AstraZeneca's CEO shared a rare, testable claim about AI with CNBC.

AstraZeneca is emerging as a potential new contender in the booming obesity treatment market after its experimental ...

U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country -- ...

President Donald Trump has not shied away from making demands of private industry, and he formalized one of them last week. On Thursday, he sent letters to 17 pharmaceutical companies, demanding that ...

AstraZeneca AZN is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 4.39% ...

AstraZeneca (AZN Quick Quote AZN - Free Report) stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a significant portion of this price decline is ...

AstraZeneca’s SOUNDTRACK-F1 study aims to improve on related risks seen with chemotherapy-including treatments in follicular ...

AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. Pfizer CEO Albert Bourla appeared with ...

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration - though much of what it is ...

ZERO Prostate Cancer, the nation's leading prostate cancer organization dedicated to advocacy, awareness, education, and ...